DME Manufacturer Kickbacks: Free Services, Discounts and Manufacturer-Backed Loans

DME manufacturer kickbacks can take the form of free services, discounts or loans the manufacturer backed, offered to steer equipment orders paid by federal health care programs. A durable medical equipment manufacturer can pay a supplier’s operating costs, supply a clinic’s equipment or finance inventory to win the business that follows. The employee who sees the arrangement may work in sales, account management or finance, far from the Medicare claim. The useful question is what the customer received and what business the manufacturer expected in return.

How the Manufacturer Reaches the Medicare Claim

The durable medical equipment manufacturer makes the equipment, the clinician orders it and the supplier bills for it. A benefit can enter that chain before anyone submits a claim: free outreach for a supplier, equipment for a sleep lab or discounts for a practice choosing which product to prescribe.

Medicare’s public durable medical equipment claims files identify the billing supplier, not the manufacturer. The supplier’s bill and the manufacturer’s sales agreement therefore show different parts of the transaction. A claim can identify the product category and the ordering provider while leaving the commercial arrangement behind the order out of view.

That distance does not keep the manufacturer out of a False Claims Act case. In its Respironics settlement announcement, the Department of Justice described how kickbacks allegedly caused suppliers to submit false claims to Medicare, Medicaid and TRICARE. The manufacturer allegedly supplied the inducement, and the suppliers submitted the claims. Patients and taxpayers lose when financial incentives decide whose equipment gets ordered.

The ordering side of this business is spread across many clinicians, while billing is concentrated among fewer suppliers. That is why an outreach service or a useful set of prescribing data can matter as much as a payment.

ResMed’s Free Services Reached the Resupply Business

ResMed agreed in January 2020 to pay more than $37.5 million to resolve allegations involving benefits at several points in the sleep-apnea business. The government alleged that it provided suppliers with free telephone call-center and patient-outreach services that helped them order resupplies for patients.

The same settlement covered alleged free and below-cost masks and diagnostic machines for sleep labs, with free installation. It also covered interest-free equipment loans for suppliers that ResMed backed in full and free ApneaLink home sleep-testing devices for physicians who were not sleep specialists.

One whistleblower complaint described a direct connection between the free service and the manufacturer’s share of the supplier’s sales:

The complaint also alleged that customers received quarterly reports showing patient numbers, market share and dollars saved. Those reports connect what the manufacturer paid for to the business it wanted. The alleged incentive was a supplier’s recurring expense taken off its books.

Resupply explains the attraction. A CPAP machine begins a patient relationship that can continue through replacement masks, tubing, filters and headgear. In its fiscal 2026 annual filing, ResMed reported that masks and other consumables supplied 42% of its Sleep and Breathing Health revenue. A service that keeps replacement orders coming supports the continuing sale of those supplies.

Respironics Paid to Resolve Separate Allegations

Respironics’ call-center services, prescribing data and supplier financing produced separate settlements. Each put a different customer expense or sales advantage at the center of the allegation.

Free Call-Center Services for Mask Customers

Respironics agreed to a $34.8 million settlement in March 2016 over allegations that it gave free call-center services to suppliers buying its sleep-apnea masks. The whistleblower’s complaint described a supplier owner who said tight margins drove him toward the free service and toward moving patients to Respironics products.

Testimony at the House Ways and Means Committee’s 2003 hearing, Waste, Fraud, and Abuse described Medicare sometimes paying more than three times suppliers’ acquisition costs for certain equipment and supplies. A manufacturer’s offer to remove a business expense reaches directly into the supplier’s margin.

Free Prescribing Data to Find More Business

In September 2022, Respironics agreed to pay over $24 million to resolve allegations that it gave suppliers free physician-prescribing data to help their marketing. The alleged claims involved ventilators, oxygen concentrators, CPAP and BiPAP machines, and other respiratory equipment.

The whistleblower’s complaint described data that suppliers could use to identify physicians to approach. It also alleged that employees became more careful about describing the arrangement after a warning:

The alleged change in wording gives the internal correspondence a purpose beyond showing that data changed hands. It can show what employees understood about the arrangement while it continued. A Respironics employee brought a qui tam case. The Justice Department said that whistleblower would receive approximately $4.3 million from the federal settlement amount.

A DME Supplier Interest-Free Loan Backed by the Manufacturer

A durable medical equipment supplier interest-free loan backed by the manufacturer was the subject of a separate Respironics settlement announced later that September. The government alleged that Respironics helped a supplier obtain a twelve-month loan and backed all of it. The settlement was $1,283,825.

The alleged benefit was financing: the supplier could acquire inventory without paying interest, with the manufacturer standing behind the loan. The financing agreement and the manufacturer’s backing show value that a product invoice alone would miss.

Can a Doctor’s Office Get a Kickback for Referrals?

Not lawfully, but it happens. Alleged manufacturer kickbacks have included free supplies and cost savings offered to doctors’ practices to influence what they prescribe. The C.R. Bard catheter case shows how the benefit can connect to the prescription form itself.

Bard and Liberator Medical Supply were among the companies covered by a $17 million settlement announced in January 2025. The government alleged that discounts, excessive free samples and savings on in-office supplies encouraged urology practices to use Bard’s Link prescription form for intermittent catheters.

In the government’s account, the practice received the benefit and the form reached the product decision. An account team could see the sample shipments, discount terms and requests to use the form together. A claim reviewer looking only at the catheter bill would be looking later in the process.

The whistleblower was a former employee of another medical-supply company. Knowledge of the arrangement did not have to come from inside the manufacturer.

Vision Quest’s Commissions Followed Each Brace

Vision Quest Industries agreed in August 2022 to pay $2,250,000 over allegations that it caused Osteo Relief clinics to bill Medicare for knee braces obtained through kickbacks. The manufacturer used an independent sales representative who, according to the government, could tell the clinics which braces to order.

The alleged commissions ranged from 20% to 35% of Vision Quest’s net revenue on each brace ordered by the clinics. The government said the arrangement made Vision Quest the clinics’ exclusive brace supplier and secured millions of dollars in annual brace sales. The payment formula and the representative’s influence over purchasing explain the alleged exchange.

The investigation began with Medicare claims-data analysis and also led to separate settlements with clinics and other participants. The billing pattern brought investigators to the business arrangement behind it. A manufacturer insider may know that arrangement from the commission records before seeing a single Medicare claim.

What Evidence Is Needed to Report Medicare Fraud?

For manufacturer kickbacks, the useful evidence connects the benefit to the customer’s decision and the resulting government-paid business. The cases point to records sales, finance and account teams may already know:

• Call-center agreements and outreach reports showing who paid for resupply services and how eligibility depended on product sales.
• Discount schedules, sample shipments and prescription forms connecting office savings to product selection.
• Loan agreements and the manufacturer’s backing showing how inventory was financed and who carried the obligation.
• Commission statements, clinic orders and internal correspondence connecting compensation to purchases or referrals.

Together, these records can explain why the orders moved. The supplier’s claims supply another part of the connection. We work with you to bring those parts into the same account of the conduct.

The civil enforcement picture extends beyond Medicare. The Department of Health and Human Services’ Office of Inspector General, in its Medicaid Fraud Control Units Fiscal Year 2023 Annual Report, published in 2024, found that medical-device manufacturers and durable medical equipment suppliers were the provider types associated with the most civil settlements and judgments that year.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Know What Won the Account

If you know which free service, loan or discount won the equipment business, speak with our whistleblower experts about the arrangement. We work beside you to connect the manufacturer’s offer, the customer’s decision and the claims, and build your strongest manufacturer-kickback case. We bring in healthcare fraud whistleblower lawyers who understand equipment sales and referral arrangements, and stay with you through the case.